PubMed Health⌕ Search

PubMed · 10198531

Pulsewidth optimisation for transformer-coupled transcutaneous current pulse generation.

Abstract

A general theoretical approach for the determination of the optimum pulsewidth used for TENS/EMS/FES is presented. Analysis based on the interaction between a step-up transformer-coupled nerve stimulator and an electrode-tissue load modelled as a simple lossy capacitive load results in excellent agreement between the predicted and measured performance. The analysis shows that, by adjusting the pulsewidth (PW) of a push-pull symmetric square waveform such that PW = 4.5 tau, the total charge delivered to the tissue load can be minimised without impacting the efficiency of the nerve stimulation. Additionally, by minimising the charge exchange supported portion of the current pulse, which is primarily responsible for the pH shift and subsequent tissue burning with long-term use, the latter can be reduced to an acceptable level.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P T Kolen. 1998. Pulsewidth optimisation for transformer-coupled transcutaneous current pulse generation.. https://doi.org/10.1007/bf02523216

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Compulsions, Parkinson's disease, and stimulation.

Pathophysiological models suggest that obsessive compulsive disorder (OCD) might be associated with dysfunctions in cortico-striato-pallido-thalamo-cortical neuronal circuits. We implanted subthalamic electrodes to alleviate parkinsonian symptoms in two patients who had Parkinson's disease and a history of severe OCD. Parkinsonian disability improved postoperatively in both patients, and 2 weeks after the procedure, their compulsions had disappeared and obsessive symptoms improved (58% improvement for patient 1 on the Yale-Brown obsessive compulsive scale, 64% for patient 2). The improvements in these two patients suggest that high-frequency stimulation could improve function in the subcortical-limbic circuitry in patients with severe OCD.

Electric Stimulation Therapy↗

The evolving place of vagus nerve stimulation therapy.

Approximately 40% of patients with epilepsy have seizures that do not adequately respond to medical therapy. Vagus nerve stimulation (VNS) therapy, approved 5 years ago by the Food and Drug Administration, offers a therapeutic option for patients with pharmacoresistant seizures. This supplement updates developments with VNS therapy since its approval and suggests future directions for this still-evolving treatment.

Electric Stimulation Therapy↗